Almost every provider I’ve ever known claims that their patients are more complex and challenging to manage than others. This perspective is especially true when providers review quality or cost efficiency data that shows them performing lower than their peers.The good news is that CMS has a system to account for clinical complexity and uses this risk adjustment methodology to ensure they are comparing apples to apples and not apples to oranges in value-based reimbursement (VBR) programs (e.g., MACRA and Medicare Advantage). The bad news is that very few providers know how Medicare’s model works and how they can take steps to make sure their data is appropriately risk-adjusted. Here are the key details to remember:
Monitored: For a condition like diabetes, this would include monitoring the progression of this disease over time, e.g., did the patient develop diabetic-related eye disease, kidney disease, nerve damage, or other complications of diabetes?
Evaluated: Continuing with diabetes, this might involve specific tests like hemoglobin A1C levels, urine protein/albumin levels, renal function testing, or eye exams.
Assessed: For diabetes, the provider needs to document whether the condition is stable, progressing, or regressing/resolved.
Treated: Finally, as it relates to diabetes, this might involve the prescription of oral hypoglycemic agents, insulin, or other diabetic treatment measures.